CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 254 filers reported holding CRISPR THERAPEUTICS AG in Q4 2019. The put-call ratio across all filers is 1.45 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $11,024,000 | -25.7% | 150,000 | -57.1% | 0.09% | -30.7% |
| Q1 2020 | $14,844,000 | -30.4% | 350,000 | 0.0% | 0.13% | -11.8% |
| Q4 2019 | $21,317,000 | -7.2% | 350,000 | -37.5% | 0.14% | -16.8% |
| Q3 2019 | $22,969,000 | -2.5% | 560,367 | +12.1% | 0.17% | +13.1% |
| Q2 2019 | $23,550,000 | -9.1% | 500,000 | -31.0% | 0.15% | -21.5% |
| Q1 2019 | $25,897,000 | -27.5% | 725,000 | -42.0% | 0.20% | -25.6% |
| Q4 2018 | $35,713,000 | -20.9% | 1,250,000 | +22.7% | 0.26% | -1.9% |
| Q3 2018 | $45,175,000 | -10.7% | 1,018,594 | +18.3% | 0.27% | -14.4% |
| Q2 2018 | $50,575,000 | +71.5% | 860,700 | +33.4% | 0.31% | +52.9% |
| Q1 2018 | $29,483,000 | +46.2% | 645,000 | -24.9% | 0.20% | +24.4% |
| Q4 2017 | $20,160,000 | – | 858,602 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gilfoyle Management LLC | 150 | $6,376 | 12.96% |
| Versant Venture Management, LLC | 498,558 | $22,629,548 | 12.03% |
| NEA Management Company, LLC | 1,587,854 | $72,072,693 | 5.57% |
| ARK Investment Management | 7,163,118 | $325,133,913 | 2.49% |
| Nikko Asset Management Americas, Inc. | 3,465,470 | $157,263,029 | 1.88% |
| Integral Health Asset Management, LLC | 275,000 | $12,482,250 | 1.73% |
| Merlin Capital, Inc | 9,092 | $412,686 | 1.54% |
| Del-Sette Capital Management, LLC | 33,977 | $1,542,216 | 1.52% |
| Green Alpha Advisors, LLC | 34,880 | $1,583,203 | 1.22% |
| Ikarian Capital, LLC | 2,039 | $9,255,021 | 1.11% |